Literature DB >> 32590617

Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review.

Timothy D Malouff1, Sunil Krishnan1, Christopher L Hallemeier2, Michael G Haddock2, Bradford S Hoppe1, Chris Beltran2, Anita Mahajan2, Daniel M Trifiletti.   

Abstract

Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness, which increase the cell kill while potentially reducing toxicities to nearby normal tissues. Although small, early clinical studies have shown promise in both the resectable and unresectable settings to improve local control and overall survival while minimizing toxicities. Currently, there are several trials, including 2 sponsored by institutions in the United States, investigating the role of carbon ion radiotherapy for the treatment of locally advanced pancreatic cancer.

Entities:  

Mesh:

Year:  2020        PMID: 32590617     DOI: 10.1097/MPA.0000000000001566

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

Review 1.  Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology.

Authors:  William A Hall; Mandana Kamgar; Beth A Erickson; Sara Beltrán Ponce; Susan Tsai; Marja T Nevalainen; Kathleen K Christians; Ben George; Kulwinder S Dua; Abdul H Khan; Douglas B Evans; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2021-10-06       Impact factor: 9.237

2.  New Perspectives for Pancreatic Cancer Treatment. Will We Be Able to Ensure Equity to Care?

Authors:  Lorenzo Cobianchi; Francesca Dal Mas
Journal:  Surg Innov       Date:  2021-12-04       Impact factor: 1.785

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.